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ABSTRACT  
Essential oils are a mixture of volatile and natural substances, identified and characterized by the strong odor, produced by aromatic plants as 
secondary metabolites. Their metabolites have a wide range of applications and have been commercially important to the pharmaceutical, food and 
cosmetic industries. One of the plants essential oil Geraniol, a monoterpene alcohol has the verity of pharmacological activities are reported in 
preclinical studies. Generally, monoterpenes are non nutritive dietary components found in the essential oils of citrus fruits and other plants. 
Geraniol has antibacterial, antiseptic, anti-inflammatory, in vivo and in vitro anticancer against in leukemia, hepatoma, melanoma and pancreatic 
cancer cell lines, and activity on lipid metabolisms and Mevelonate metabolisms. In this review, article highlights the important pharmacological 
activities of plant essential oil geraniol. 
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INTRODUCTION 
Essential oils are also called volatile oils, are generally odorous aromatic. 
It is found in the various parts of the plant, and these are used in the 
cosmetic, medical and food industry [1]. These Essential oils are 
composed mainly of terpenes and phenilpropens, but the majority of 
essential oils contain predominantly (90%) terpenes [2]. These terpenes 
are in different forms as mono, di, try, tetra terpenes; in that mono 
terpenes have ten carbons, sesquiterpenes with fifteen carbons and 
diterpenes with twenty carbons [3]. These terpenes are isolated from 
many traditional and medicinal plants are using as the new class of 
pharmacological active molecules for various diseased conditions [4].  
Recent trends of preclinical research focused on the herb oils that 
possess hypolipidemic, antiplatelet, antitumor or immune-
stimulating properties that may be useful adjuncts in helping reduce 
the risk of cardiovascular disease and cancer [5]. It was found that, 
there were plenty of biologically active mixtures from the plant 
essential oils, mainly terpenoids like linalool, geraniol, boreneol, 
menthol, thujanol, citronnillol, α-terpineol and a variety of low 
molecular weight aliphatic hydrocarbons like phenols are thymol, 
carvacrol, eugenol, gaiacol and aromatic aldehydes are 
cinnamaldehyde, cuminal and phellandral [6]. Geraniol (fig. 1) (3, 7-
dimethyl-2, 6-octadien-1-ol) an acyclic monoterpene mainly found in 
citurs fruits, lemongrass and aromatic herb oils [7]. Pure geraniol is 
colorless oily liquid and insoluble in water. It is primary part of rose 
oil, palmarosa oil, and citronella oil [8]. In this, review pointed out the 
various pharmacological effects of geraniol such as antimicrobial, 
antibacterial, anticancer, anti-inflammatory, anti-oxidant, HMG-CoA 
reductase activity, Neuroprotectivity and Hepatoprotectivity.  
 
 
Fig. 1: Structure of geraniol 
Antimicrobial activity 
The success of treatments highly relates to the effectiveness of 
antimicrobial agents to eliminate the living microorganisms from an 
infected body [9]. Hence studying the antimicrobial activity of 
pharmacological agents is more important in therapeutics. Essential 
oils are mixtures of volatile secondary metabolites have 
antibacterial and antifungal activity [10]. Arldogan et al., 2002 
evaluated the antimicrobial activity of geraniol against bacteria and 
fungi by disc diffusion method individually and mixture of essential 
oils from Rosa damascene. In this case, geraniol inhibits 
Staphylococcus aureus strains and Escherichia coli strains by the 
inhibition zone was 8 mm reported [11].  
Pattnaik et al., 1997 reported that geraniol along with few other 
aromatic constituents of essential oils were tested the antimicrobial 
activity against eighteen bacteria including Gram-positive cocci and 
rods, and Gram-negative rods and twelve fungi three yeast-like and 
nine filamentous [12]. In terms of antimicrobial activity, geraniol 
showed maximum efficacy [13, 14]. Mesa Arango et al., 2009 
reported the antifungal activity of geraniol and citronellal 
chemotypes from the essential oils of Colombian Lippia alba (mill.) 
N. E, at lower concentration of geraniol shows significant antifungal 
activity against Candida krusei and Aspergillus fumigates with GM-
MIC values of 49.6 microg/ml and 176.8 microg/ml respectively 
[15]. The potential antibacterial activity of geraniol was 
demonstrated by Singh et al., 2012 [16] against Gram-positive and 
Gram-negative bacteria pathogens and antifungal activity against 
dermatophytes, yeasts Aspergillus species and Candida albicans 
strains [17, 18]  
Anti-inflammatory activity 
Inflammation is a complex biological response of vascular tissues 
against aggressive agents such as pathogens, irritants, or damaged 
cells [19]. The immunosuppressive activity of geraniol was reported 
in vitro with lymphocyte proliferation assays and in vivo in a rat 
cardiac allograft transplant model [20]. It is an example of 
isoprenoid drugs that enters the mevalonate pathway and is capable 
of reverting the genetic or pharmacological inhibition [21]. Since 
available anti-inflammatory drugs exerted an extensive variety of 
side effects, whereas geraniol showed significant anti-inflammatory 
activity with fewer side effects [22]. Tricarico et al. 2013 reported 
geraniol modulates the enzymatic pathway and partially rescues the 
inflammatory phenotype associated with defective mevelonic 
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pathway [23]. Another study, geraniol along with other natural 
terpenes prevent the nimesulide induced cellular damage and 
inflammation on hepatocytes [24]. Tsai et al., 2011 reported the 
essential oil of Cymbopogon martinii has the high content of geraniol 
which modulate/reduce the inflammatory markers TNF-α, IL-1β, and 
IL-8 secretion [25]. Citronellol and geraniol, the major components of 
rose oil, activated peroxisome proliferator-activated receptor (PPAR) 
α and γ, and suppressed Lipopolysaccharide (LPS)-induced 
cyclooxygenase-2 (COX-2) expression in cell culture assays, and also 
suppresses TNF-α induced neutrophil adherence at low concentration 
[26], indicating the anti-inflammatory activity of geraniol [27].  
Anticancer activity 
Numerous epidemiological studies consistently showed that high 
intake of fruits, and vegetables present productive action against 
different cancer types [28]. Hence diet derived terpenoids represent 
promising anticancer agents [29]. Geraniol has been reported to 
possess in vivo and in vitro anticancer activity against various 
cancers. Soon young Paik et al., 2005 reported the essential oils from 
Zanthoxylum schinifolium had thirty three compounds and geranyl 
acetate was the most abundant among the constituents, this showed 
anticancer activity against HepG2 human hepatoma cell lines [30]. It 
also reported that geraniol inhibit growth of leukemia and 
melanoma cells [31], Hepatoma cells [32] and pancreatic cancer cells 
[33]. Furthermore, the compound has no cytotoxic activity, 
indicating that geraniol exerts mainly cytostatic effects on human 
colon cancer cells [34]. Carnesecchi et al., 2004 reported that the 
treatment with geraniol at low concentration potentiates 5-
Fluorouracil mediated growth inhibition of human colon cancer cell 
lines [35]. The anticarcinogenic action of geraniol was studied when 
administered continuously during the initiation and selection phase 
of hepatocarcinogensis [36]. Our previous study reported the 
anticancer effect of geraniol against chemically induced oral cancer 
in rats [7]. Geraniol inhibits cancer cell proliferation by modulating 
the expression of Proliferative cell nuclear antigen (PCNA), cyclin 
D1, and c-fos against DMBA-induced hamster buccal pouch 
carcinogenesis [37]. It invokes a p21cip1 and p27kip1
Apoptosis is programmed cell death; it has been recognized to play 
an important role in the maintenance of tissue homeostasis and 
cancer by the selective elimination of excessive cells [40]. 
Additionally, induction of apoptosis of cancer cells is recognized as a 
valuable tool for cancer treatment [41]. Geraniol inhibits cancer cell 
proliferation and DNA damage while induction of apoptosis 
specifically related to anticancer effect against initial phases of 
hepatocarcinogenesis [42]. At a molecular level, geraniol inhibited 
AKT signaling and activated AMPK signaling, resulting in mTOR 
inhibition leads to apoptosis in PC-3 Prostate cancer cells [43]. 
Geraniol regulates the expressions of apoptotic proteins Bcl-2, Bax 
and cytochrome-C thereby initiates apoptosis in coloncarcinogenesis 
[44, 34], Prostate cancer [45] lung adenocarcinoma [46] and 
Hepatocarcinogenesis [36].  
 dependent 
antiproliferative mechanisms in human pancreatic adenocarcinoma 
cells [38]. Geraniol synergistically inhibits cholesterol biosynthesis 
and proliferation of Hep G2 cell line [39].  
HMG-CoA reductase activity 
3-Hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase, the rate 
limiting enzyme in the biosynthesis of cholesterol and other sterols, 
catalyzes the formation of mevalonate, is required for DNA synthesis and 
proliferation [47]. Increased level of mevalonate promotes call growth 
and proliferation, so it is important to inhibit the mevalonate synthesis 
during the development of new chemotherapeutic agents [48]. Robin et 
al., 2004 reported geraniol exerts HMG-CoA reductase activity in MCF-7 
human breast cancer cell [49].  
Antioxidant activity 
Antioxidants have been reported to prevent oxidative damage 
caused by free radical and can be used in Cardiovascular, 
Neurological diseases, Cancer and Inflammatory diseases [50]. Our 
previous study reported the antioxidant activity of geraniol against 
4-Nitroquinoline-1-oxide induced oral carcinogenesis in rats [7, 51]. 
Geraniol enhance the production of antioxidants by activating 
Nuclear factor E2-related factor 2 (Nrf2) is a key component to 
cellular redox homeostasis; thereby Product cellular oxidative 
damage caused by free radicals in the diseased model. [52]. Khan AQ 
et al., 2013 reported geraniol protects 12-O-tetradecanoyl phorbol-
13-acetate induced oxidative damage by expressions of antioxidant 
response markers, glutathione (GSH) content and the activity other 
antioxidant enzymes [53]. In addition, geraniol inhibits abnormal 
cell proliferation occurring in skin carcinogenesis by modulating the 
activities of Phase II detoxification agents and through free radical 
scavenging potential was reported by Manoharan et al., 2012 [54], 
and it modulates Phase I and Phase II detoxification enzymes in 
experimental oral carcinogensis is reported by madankumar et al., 
2013 [7], which shows the strong antioxidant efficacy of geraniol. 
Anti-ulcer activity 
Silva et al., 2012 reported the monoterpene constituent of essential 
oils has the anti-ulcer activities in experimental models of edema 
induced by different phlogistic agents and gastric lesions were induced 
by acetic acid [55]. De Carvalho KI et al., 2013 studied Oral treatment 
with geraniol in ethanol induced gastric ulcer in experimental rats, 
significantly decreased the number of ulcerative gastric lesions by 70 
% to 99 %, and it was participates in the gastroprotective effects 
against different ulcerogenic agents by increasing GSH levels (an 
endogenous antioxidant factor) and decreasing MPO activity (an 
inflammatory marker) in gastric and duodenal tissue [56]. Plant 
essential oils have antiulcer activity against aspirin plus, pylorus, 
ligation, aspirin and ethanol induced rats and terpenes possessed with 
significant antiulcer activity against different ulcer causing agents in 
experimental animal models [57].  
Neuroprotectivity  
Neuroprotective effect of geraniol was reported by Prasad and 
Muralidhara, 2014 by assessing the ameliorative effect of geraniol 
against an acrylamide induced oxidative stress, mitochondrial 
dysfunction and neurotoxicity in a Drosophila melanogaster model 
[58]. Brain derived Neurotrophic factors and glial cell derived 
neurotrophic factors, could prevent or halt the progress of 
neurodegeneration in Parkinson’s disease [59]. Neuroprotective 
efficacy of geraniol was affirmed by improved motor coordination, 
expressions of neurotrophic factors, and inhibiting oxidative stress, 
increasing the counts of dopaminergic immunoreactive neurons and 
it prevents oxidative stress-related neurodegenerative disorders 
such as Parkinson’s disease [60].  
Hepatoprotectivity  
Ong et al., 2012 reported the Dietary isoprenic derivatives such as 
geraniol on hepatocarcinogenesis may involve a block in carcinogen 
activation, induction of phase 2 enzymes and an antioxidant activity, 
as well as interference with cellular processes including cell 
communication, proliferation, apoptosis, differentiation and 
remodeling of preneoplastic lesions [61]. Singh et al., 2012 studied 
the preventive effective of natural terpenes on Nimesulide induced 
cellular damage from elevated SGPT, SGOT, bilirubin and histo-
pathological changes, Antioxidants and key redox enzymes (iNOS, 
mtNOS, Cu/Zn-SOD, Mn-SOD, GPx and GR) were studied significantly 
to ensuing hepatoprotectivity [62].  
CONCLUSION  
Plant essential oils are the most important source for exploring 
potentially useful structural compounds for developing new 
therapeutic drugs. Geraniol, an important constituent of essential oil 
of ginger, lemon, lime, lavender, nutmeg, orange, rose, etc. It is an 
acyclic mono terpenoid and is the main component of oil-of-rose and 
palmarosa oil has been used to treat various diseases for several 
years. The present review reports the diverse pharmacological 
potentials which are explored by different researchers. However, 
more biological potentials are still untapped. The geraniol and 
related metabolites are used in the traditional system of medicine 
for various diseases related to the human race. 
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